MedTrace Logo

Hypoglycemia and Glucagon Response in CF

NCT05700604 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 53

Last updated 2023-01-26

No results posted yet for this study

Summary

The goal of this clinical trial is to investigate the etiopathogenesis of isolated hypoglycemia and hypoglycemia with abnormal glucose tolerance in children with Cystic Fibrosis (CF) and to evaluate the role of glucagon and pancreatic insufficiency on hypoglycemia in CF. The main questions it aims to answer are:

1. Do isolated hypoglycemia and hypoglycemia with abnormal glucose tolerance have different etiopathogenesis?
2. What is the role of pancreatic insufficiency in these two conditions? Participants were asked to perform 3-h OGTT and to take blood samples. Researchers compared with healthy peers to see if there is isolated hypoglycemia in OGTT and how is the glucagon response to OGTT in healthy peers.

Conditions

Sponsors & Collaborators

  • Yeditepe University

    collaborator OTHER

  • Marmara University

    lead OTHER

Principal Investigators

  • Belma Haliloglu, MD,PhD · Marmara University, School of Medicine, Department of Pediatric Endocrinology

Eligibility

Min Age
10 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05700604 on ClinicalTrials.gov